RE: Different perspective30 May 2022 16:02
Smeeno. LTb,
Previously Labskin had been sold as a one-off product for about £1,500.
The customer was corporate R&D labs.
Brandon’s plan was to sell it, not to companies’ R&D teams, but to their
marketing teams. From his Alltracel days, Brandon knew a bit about
skincare marketing. He knew that marketing teams wanted to make big
science-backed claims on the side of their products. And he knew that
making those claims was expensive — between labs, trials, test subjects,
it cost about £200,000 to run a scientific study.
Brandon’s plan was to use Labskin to run these trials much more
cheaply. Instead of charging R&D labs a one-off £1,500, Integumen
started charging marketing teams a recurring £50,000.
“We went from a turnover of £49,000 in the first half of 2018, to nearly
£300,000 by the end of the year,” Brandon said. “So it was: okay, now
we’ve got something here. Let’s just move this faster.”